-
1by Mayumi Ikeda, Yu Ishima, Victor T. G. Chuang, Maki Sakai, Hiroki Osafune, Hidenori Ando, Taro Shimizu, Keiichiro Okuhira, Hiroshi Watanabe, Toru Maruyama, Masaki Otagiri, Takaaki Akaike, Tatsuhiro IshidaGet full text
Published 2019-04-01
Article -
2by Hidenori Ando, Takashi Mochizuki, Amr S. Abu Lila, Shunsuke Akagi, Kenji Tajima, Kenji Fujita, Taro Shimizu, Yu Ishima, Tokuo Matsushima, Takatomo Kusano, Tatsuhiro IshidaGet full text
Published 2021-06-01
Article -
3by Takuma Takayama, Taro Shimizu, Amr S. Abu Lila, Yuki Kanazawa, Hidenori Ando, Yu Ishima, Tatsuhiro Ishida“... immunity in the overall therapeutic effects of Doxil<sup>®</sup>. Manipulating pharmacokinetics...”
Published 2020-10-01
Get full text
Article -
4
-
5by Ryo Kinoshita, Yu Ishima, Victor T. G. Chuang, Hiroshi Watanabe, Taro Shimizu, Hidenori Ando, Keiichiro Okuhira, Masaki Otagiri, Tatsuhiro Ishida, Toru MaruyamaGet full text
Published 2021-08-01
Article -
6by Hidenori Ando, Noriko Saito-Tarashima, Amr S. Abu Lila, Nozomi Kinjo, Taro Shimizu, Yu Ishima, Noriaki Minakawa, Tatsuhiro IshidaGet full text
Published 2020-04-01
Article -
7by Hidenori Ando, Masakazu Fukushima, Kiyoshi Eshima, Taichi Hasui, Taro Shimizu, Yu Ishima, Cheng‐Long Huang, Hiromi Wada, Tatsuhiro IshidaGet full text
Published 2019-12-01
Article -
8“... and pharmacokinetic properties are highly desirable. The S-nitrosothiol fraction in plasma is largely composed...”
Get full text
Article -
9